Krystal Biotech Inc (KRYS)

157.70 +1.06 (+0.68%) USD  |  NASDAQ  |  Dec 19, 10:24
More

Krystal Biotech Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cost of Goods Sold Definition

View Cost of Goods Sold Definition
Start Trial

Cost of Goods Sold (COGS) is the measure of direct costs related to the production of goods. Includes the cost of obtaining raw materials and direct labor costs.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Bioventus Inc Upgrade
ADMA Biologics Inc Upgrade
Alnylam Pharmaceuticals Inc Upgrade
Amicus Therapeutics Inc Upgrade
Insmed Inc Upgrade